Table 1.
Published article characteristics (n=54).
| Characteristic | n (%) | |
| Publication country of origin (n=54) | ||
| Australia | 1 (2) | |
| Canada | 5 (9) | |
| China | 1 (2) | |
| Finland | 2 (4) | |
| Germany | 1 (2) | |
| Netherlands | 4 (7) | |
| Norway | 7 (13) | |
| Portugal | 1 (2) | |
| Slovenia | 1 (2) | |
| Spain | 2 (4) | |
| Sweden | 2 (4) | |
| Switzerland | 1 (2) | |
| United States | 26 (48) | |
| Unique studies (n=53) | ||
| Original study | 48 (91) | |
| Protocol | 4 (7.5) | |
| Editorial or commentary | 1 (2) | |
| Study context or setting of use (n=53) | ||
| Academic (ie, Department of behavioral sciences) | 4 (7.5) | |
| Business (ie, CVS and Walmart) | 1 (2) | |
| Integrated health care organization (ie, Kaiser Permanente) | 2 (4) | |
| Primary care | 19 (36) | |
| Tertiary care outpatient clinics | 27 (51) | |
| Population (n=53) | ||
| Adults or all | 49 (92) | |
| Pediatrics (<18 years) | 4 (7.5) | |
| Disease or clinical area of interest (n=68)a | ||
| Cardiovascular disease or stroke | 6 (9) | |
| Chronic respiratory condition | 10 (15) | |
| Diabetes | 20 (29) | |
| Mental health | 8 (12) | |
| Chronic pain | 5 (7) | |
| Other | ||
| Dermatology | 2 (3) | |
| Irritable bowel disease or syndrome | 2 (3) | |
| Cerebral palsy | 1 (1.5) | |
| Human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) | 1 (1.5) | |
| Rheumatic disease | 1 (1.5) | |
| Obesity | 1 (1.5) | |
| Hypertension | 2 (3) | |
| Fibromyalgia | 2 (3) | |
| Cystic fibrosis | 1 (1.5) | |
| Impaired mobility | 1 (1.5) | |
| Nonspecific (Chronically ill) | 5 (7) | |
aSome studies evaluated the tool in multiple contexts, for example, in diabetes and mental health.